Microbot Medical expands LIBERTY commercial footprint to seven Eastern U.S. states
Microbot Medical announced that a Pennsylvania academic health system adopted the LIBERTY Endovascular Robotic System, extending the company’s account footprint across seven Eastern U.S. states.
Evidence notes
- Microbot said the system spans multiple hospitals and specialty centers serving Pennsylvania and New Jersey.
- The company said LIBERTY now has accounts across seven Eastern U.S. states.
Company context
Microbot Medical develops LIBERTY, a compact single-use endovascular robotic system designed for remotely operated vascular access and navigation.